175 related articles for article (PubMed ID: 31279151)
1. Carbapenem-resistant Enterobacteriaceae in hematological patients: Outcome of patients with Carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization.
Zhang L; Zhai W; Lin Q; Zhu X; Xiao Z; Yang R; Zheng Y; Zhang F; Li S; Wang C; Feng S; Han M; Wang J
Int J Antimicrob Agents; 2019 Oct; 54(4):527-529. PubMed ID: 31279151
[No Abstract] [Full Text] [Related]
2. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
Correa AAF; Fortaleza CMCB
Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate.
Salomão MC; Guimarães T; Duailibi DF; Perondi MBM; Letaif LSH; Montal AC; Rossi F; Cury AP; Duarte AJS; Levin AS; Boszczowski I
J Hosp Infect; 2017 Nov; 97(3):241-246. PubMed ID: 28826688
[TBL] [Abstract][Full Text] [Related]
5. How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?
Goodman KE; Simner PJ; Klein EY; Kazmi AQ; Gadala A; Rock C; Tamma PD; Cosgrove SE; Maragakis LL; Milstone AM;
Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1491-1493. PubMed ID: 30269700
[TBL] [Abstract][Full Text] [Related]
6. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
Bartoletti M; Tedeschi S; Pascale R; Raumer L; Maraolo AE; Palmiero G; Tumietto F; Cristini F; Ambretti S; Giannella M; Lewis RE; Viale P
Int J Antimicrob Agents; 2018 Mar; 51(3):516-521. PubMed ID: 29410250
[TBL] [Abstract][Full Text] [Related]
7. Predictors for gut colonization of carbapenem-resistant Enterobacteriaceae in neonates in a neonatal intensive care unit.
Singh NP; Choudhury DD; Gupta K; Rai S; Batra P; Manchanda V; Saha R; Kaur IR
Am J Infect Control; 2018 Jun; 46(6):e31-e35. PubMed ID: 29803234
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.
Hwang JH; Park JS; Lee E; Bae JY; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh M; Kim HB
J Hosp Infect; 2018 Aug; 99(4):487-491. PubMed ID: 29476883
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China.
Fang L; Lu X; Xu H; Ma X; Chen Y; Liu Y; Hong G; Liang X
Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31281931
[TBL] [Abstract][Full Text] [Related]
10. Close long-term contacts between individuals with discordant colonization status of carbapenem-resistant Enterobacteriaceae do not result in bacterial transmission.
Borgmann S; Rieß B; Pfeifer Y
J Hosp Infect; 2018 Aug; 99(4):429-431. PubMed ID: 29549050
[No Abstract] [Full Text] [Related]
11. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
13. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
Davido B; Moussiegt A; Dinh A; Bouchand F; Matt M; Senard O; Deconinck L; Espinasse F; Lawrence C; Fortineau N; Saleh-Mghir A; Caballero S; Escaut L; Salomon J
Antimicrob Resist Infect Control; 2018; 7():100. PubMed ID: 30123500
[TBL] [Abstract][Full Text] [Related]
14. Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.
Goodman KE; Simner PJ; Klein EY; Kazmi AQ; Gadala A; Toerper MF; Levin S; Tamma PD; Rock C; Cosgrove SE; Maragakis LL; Milstone AM;
Infect Control Hosp Epidemiol; 2019 May; 40(5):541-550. PubMed ID: 30915928
[TBL] [Abstract][Full Text] [Related]
15. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.
Dinh A; Fessi H; Duran C; Batista R; Michelon H; Bouchand F; Lepeule R; Vittecoq D; Escaut L; Sobhani I; Lawrence C; Chast F; Ronco P; Davido B
J Hosp Infect; 2018 Aug; 99(4):481-486. PubMed ID: 29477634
[TBL] [Abstract][Full Text] [Related]
16. Fecal carriage of carbapenem-resistant
Mohan B; Prasad A; Kaur H; Hallur V; Gautam N; Taneja N
Indian J Med Microbiol; 2017; 35(4):555-562. PubMed ID: 29405149
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
Muggeo A; Guillard T; Barbe C; Thierry A; Bajolet O; Vernet-Garnier V; Limelette A; Brasme L; De Champs C;
J Antimicrob Chemother; 2017 May; 72(5):1496-1501. PubMed ID: 28158526
[TBL] [Abstract][Full Text] [Related]
18. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan.
Yamamoto N; Asada R; Kawahara R; Hagiya H; Akeda Y; Shanmugakani RK; Yoshida H; Yukawa S; Yamamoto K; Takayama Y; Ohnishi H; Taniguchi T; Matsuoka T; Matsunami K; Nishi I; Kase T; Hamada S; Tomono K
J Hosp Infect; 2017 Nov; 97(3):212-217. PubMed ID: 28736270
[TBL] [Abstract][Full Text] [Related]
20. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
Richter SS; Marchaim D
Virulence; 2017 May; 8(4):417-426. PubMed ID: 27813699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
